Polymyalgia rheumatica and giant cell arteritis

Ophthalmologists are aware of the potential risks of high dose steroid treatment in elderly patients 4 and of the disastrous visual consequences of inadequate steroid treatment in giant cell arteritis. 3 Until larger randomised controlled series show that lower doses really do prevent ischaemic comp...

Full description

Saved in:
Bibliographic Details
Published in:BMJ 1995-08, Vol.311 (7002), p.455-456
Main Authors: Ferris, John, Lamb, Robert
Format: Article
Language:English
Subjects:
Bones
Corticosteroids
Dosage
Letters
Medical personnel
Older adults
Ophthalmology
Polymyalgia rheumatica
Rheumatoid arthritis
Steroids
Synovitis
Temporal arteritis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ophthalmologists are aware of the potential risks of high dose steroid treatment in elderly patients 4 and of the disastrous visual consequences of inadequate steroid treatment in giant cell arteritis. 3 Until larger randomised controlled series show that lower doses really do prevent ischaemic complications we believe that an initial dose of 20-40 mg prednisolone/day is inadequate in all patients in whom the clinical history and results of examination strongly suggest giant cell arteritis (with or without confirmatory results of temporal artery biopsy).
ISSN:0959-8138
1468-5833
1756-1833
DOI:10.1136/bmj.311.7002.455a